Cargando…
Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606026/ https://www.ncbi.nlm.nih.gov/pubmed/34849450 http://dx.doi.org/10.1002/rth2.12625 |
| _version_ | 1784602267743158272 |
|---|---|
| author | Uaprasert, Noppacharn Trithiphen, Sasinipa Sukperm, Autcharaporn Akkawat, Benjaporn Watanaboonyongcharoen, Phandee Vichitratchaneekorn, Rattaporn Tongbai, Thanisa Jantarabenjakul, Watsamon Paitoonpong, Leilani Rojnuckarin, Ponlapat |
| author_facet | Uaprasert, Noppacharn Trithiphen, Sasinipa Sukperm, Autcharaporn Akkawat, Benjaporn Watanaboonyongcharoen, Phandee Vichitratchaneekorn, Rattaporn Tongbai, Thanisa Jantarabenjakul, Watsamon Paitoonpong, Leilani Rojnuckarin, Ponlapat |
| author_sort | Uaprasert, Noppacharn |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8606026 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86060262021-11-29 Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies Uaprasert, Noppacharn Trithiphen, Sasinipa Sukperm, Autcharaporn Akkawat, Benjaporn Watanaboonyongcharoen, Phandee Vichitratchaneekorn, Rattaporn Tongbai, Thanisa Jantarabenjakul, Watsamon Paitoonpong, Leilani Rojnuckarin, Ponlapat Res Pract Thromb Haemost Letters to the Editor John Wiley and Sons Inc. 2021-11-21 /pmc/articles/PMC8606026/ /pubmed/34849450 http://dx.doi.org/10.1002/rth2.12625 Text en © 2021 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Uaprasert, Noppacharn Trithiphen, Sasinipa Sukperm, Autcharaporn Akkawat, Benjaporn Watanaboonyongcharoen, Phandee Vichitratchaneekorn, Rattaporn Tongbai, Thanisa Jantarabenjakul, Watsamon Paitoonpong, Leilani Rojnuckarin, Ponlapat Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies |
| title | Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies |
| title_full | Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies |
| title_fullStr | Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies |
| title_full_unstemmed | Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies |
| title_short | Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies |
| title_sort | safety of the second dose of the chadox1 ncov‐19 vaccine in people with persistent anti–platelet factor 4 antibodies |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606026/ https://www.ncbi.nlm.nih.gov/pubmed/34849450 http://dx.doi.org/10.1002/rth2.12625 |
| work_keys_str_mv | AT uaprasertnoppacharn safetyoftheseconddoseofthechadox1ncov19vaccineinpeoplewithpersistentantiplateletfactor4antibodies AT trithiphensasinipa safetyoftheseconddoseofthechadox1ncov19vaccineinpeoplewithpersistentantiplateletfactor4antibodies AT sukpermautcharaporn safetyoftheseconddoseofthechadox1ncov19vaccineinpeoplewithpersistentantiplateletfactor4antibodies AT akkawatbenjaporn safetyoftheseconddoseofthechadox1ncov19vaccineinpeoplewithpersistentantiplateletfactor4antibodies AT watanaboonyongcharoenphandee safetyoftheseconddoseofthechadox1ncov19vaccineinpeoplewithpersistentantiplateletfactor4antibodies AT vichitratchaneekornrattaporn safetyoftheseconddoseofthechadox1ncov19vaccineinpeoplewithpersistentantiplateletfactor4antibodies AT tongbaithanisa safetyoftheseconddoseofthechadox1ncov19vaccineinpeoplewithpersistentantiplateletfactor4antibodies AT jantarabenjakulwatsamon safetyoftheseconddoseofthechadox1ncov19vaccineinpeoplewithpersistentantiplateletfactor4antibodies AT paitoonpongleilani safetyoftheseconddoseofthechadox1ncov19vaccineinpeoplewithpersistentantiplateletfactor4antibodies AT rojnuckarinponlapat safetyoftheseconddoseofthechadox1ncov19vaccineinpeoplewithpersistentantiplateletfactor4antibodies |